Twitter | ಹುಡುಕು | |
Fiona Scott Morton
Professor of Economics, Yale School of Management. Primary research areas: competition, antitrust and healthcare
921
ಟ್ವೀಟ್‌ಗಳು
48
ಹಿಂಬಾಲಿಸುತ್ತಿರುವವರು
4,316
ಹಿಂಬಾಲಕರು
ಟ್ವೀಟ್‌ಗಳು
Fiona Scott Morton 54 ನಿಮಿ
ಇವರಿಗೆ ಪ್ರತಿಕ್ರಿಯಿಸಲಾಗುತ್ತಿದೆ @rodrikdani @Econ_Marshall ಮತ್ತು 2 ಇತರರು
It's coming!
Reply Retweet ಇಷ್ಟಪಡಿ
Fiona Scott Morton 14 ಗಂ.
ಇವರಿಗೆ ಪ್ರತಿಕ್ರಿಯಿಸಲಾಗುತ್ತಿದೆ @tylersterns @greg_ip ಮತ್ತು 4 ಇತರರು
It's a little early to use the verb "do"
Reply Retweet ಇಷ್ಟಪಡಿ
Fiona Scott Morton 14 ಗಂ.
ಇವರಿಗೆ ಪ್ರತಿಕ್ರಿಯಿಸಲಾಗುತ್ತಿದೆ @BetoHRH
With the purpose of being bought out for a share of monopoly profit rather than competing as a duopolist?
Reply Retweet ಇಷ್ಟಪಡಿ
Fiona Scott Morton ಮರುಟ್ವೀಟಿಸಿದ್ದಾರೆ
David Dayen 19 ಗಂ.
ಇವರಿಗೆ ಪ್ರತಿಕ್ರಿಯಿಸಲಾಗುತ್ತಿದೆ @ddayen
This is in support of the Staples/Essendant merger, combining the nation's largest office supply retailer with the nation's largest office supply wholesaler. Public comment closes tomorrow:
Reply Retweet ಇಷ್ಟಪಡಿ
Fiona Scott Morton 19 ಗಂ.
Problem: small tech acquisitions by large platforms are probably very hard to undo cleanly. Would a divestiture 5 yrs later improve competition? Maybe not. (Unlike dialysis clinics, my last tweet). Remedies that encourage entry might be mandatory interfaces, open APIs etc.
Reply Retweet ಇಷ್ಟಪಡಿ
Fiona Scott Morton 19 ಗಂ.
Yes. Thomas Wollmann's new paper on local dialysis center mergers might be a nice case study. HHIs in dialysis have risen almost entirely due to small mergers (<HSR) that were not reviewed by the FTC. The FTC could go back to those and require divestitures.
Reply Retweet ಇಷ್ಟಪಡಿ
Fiona Scott Morton 23 ಗಂ.
A small biotech firm w/ only one product may find the benefit of a high price for it outweighs negative publicity / regulatory response to other products (none). Manufacturers with large portfolios bear more of the consequences of overall market outcomes.
Reply Retweet ಇಷ್ಟಪಡಿ
Fiona Scott Morton ಮರುಟ್ವೀಟಿಸಿದ್ದಾರೆ
Craig Garthwaite ಫೆಬ್ರವರಿ 26
This hearing is mainly for show. But if we wanted to change that, it would be illuminating to have a Senator force the Pfizer CEO and the Janssen CEO discuss the rebate structure for Remicade and its implications for biosimliar entry. If that happens, popcorn is on me ...
Reply Retweet ಇಷ್ಟಪಡಿ
Fiona Scott Morton ಫೆಬ್ರವರಿ 24
If insurers thought a functioning ACA was their bulwark against Medicare for all then they should have been working a lot harder ($$) over the last 8 years to make Rs embrace the ACA. Now saying “we have a popular working ACA so we don’t need M4A” is bizarre.
Reply Retweet ಇಷ್ಟಪಡಿ
Fiona Scott Morton ಮರುಟ್ವೀಟಿಸಿದ್ದಾರೆ
José Azar ಫೆಬ್ರವರಿ 20
Glenn Hubbard says the idea that companies having the same owners could affect competition is "absolutely silly". says he hasn't been following the literature, points out that index funds have benefited investors (which is true; that's leg one of the trilemma).
Reply Retweet ಇಷ್ಟಪಡಿ
Fiona Scott Morton ಫೆಬ್ರವರಿ 21
ಇವರಿಗೆ ಪ್ರತಿಕ್ರಿಯಿಸಲಾಗುತ್ತಿದೆ @PGunigantiAT @BetoHRH
nice change of subject!
Reply Retweet ಇಷ್ಟಪಡಿ
Fiona Scott Morton ಫೆಬ್ರವರಿ 21
ಇವರಿಗೆ ಪ್ರತಿಕ್ರಿಯಿಸಲಾಗುತ್ತಿದೆ @PGunigantiAT @BetoHRH
80% of stocks in the US are held by the wealthiest 10% of households. Of course there are examples of every kind of pattern but it is misleading to suggest that the median consumer is as wealthy as the median owner of the flows of business profit.
Reply Retweet ಇಷ್ಟಪಡಿ
Fiona Scott Morton ಫೆಬ್ರವರಿ 21
ಇವರಿಗೆ ಪ್ರತಿಕ್ರಿಯಿಸಲಾಗುತ್ತಿದೆ @C_Garthwaite
This would be a more convincing argument if we thought healthcare was provided efficiently. If it's not, we can move to the frontier using either lower prices or higher quality.
Reply Retweet ಇಷ್ಟಪಡಿ
Fiona Scott Morton ಫೆಬ್ರವರಿ 21
ಇವರಿಗೆ ಪ್ರತಿಕ್ರಿಯಿಸಲಾಗುತ್ತಿದೆ @ProfFionasm
if there is a merger where prices rise and consumers are harmed, a court could allow the merger when it causes firms to cut costs by more (e.g. elim one HQ). If the firm's gains > consumer's losses, then society in total gains! But distn matters - ALL gains go to shareholders.
Reply Retweet ಇಷ್ಟಪಡಿ
Fiona Scott Morton ಫೆಬ್ರವರಿ 21
In case you thought there had not been *enough* redistribution from poor to rich over the last 30 years, here is R FTC Commissioner Wilson explaining how we should be switching to the total welfare standard when we enforce the antitrust laws. This means...
Reply Retweet ಇಷ್ಟಪಡಿ
Fiona Scott Morton ಫೆಬ್ರವರಿ 21
This book nicely explains how lack of competition makes a capitalist system function badly and not serve the people. You can be in favor of both capitalism and big changes to the economy when you want competitive markets.
Reply Retweet ಇಷ್ಟಪಡಿ
Fiona Scott Morton ಫೆಬ್ರವರಿ 20
Yes, except if CivicaRx tries to contract with for-profit existing drug makers, why is it in their interest to enable entry that drives down prices, doesn't earn much profit, and may cause generic rivals to retaliate? I am not sure this will work...
Reply Retweet ಇಷ್ಟಪಡಿ
Fiona Scott Morton ಫೆಬ್ರವರಿ 19
ಇವರಿಗೆ ಪ್ರತಿಕ್ರಿಯಿಸಲಾಗುತ್ತಿದೆ @C_Garthwaite
News flash: A museum is not nature.
Reply Retweet ಇಷ್ಟಪಡಿ
Fiona Scott Morton ಫೆಬ್ರವರಿ 19
This is a great article for anyone interested in competition in modern America, and in how we update enforcement of antitrust laws to handle new challenges.
Reply Retweet ಇಷ್ಟಪಡಿ
Fiona Scott Morton ಫೆಬ್ರವರಿ 19
Sometimes the best the consumers can hope for is that the fighting among corporations who want profit makes them neutralize each other and become less effective at rent extraction. Senators protecting consumer interests aren't common enough unfortunately.
Reply Retweet ಇಷ್ಟಪಡಿ